Skip to main content
Journal ArticleOPEN ACCESS

A case of myelodysplastic syndrome/myeloproliferative neoplasm ( MDS / MPN ) successfully treated with lenalidomide

  • Islam A
Clinical Case Reports (2015) 3(7) 551-552
DOI: 10.1002/ccr3.293
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Lenalidomide is an immunomodulatory drug which is used to treat patients with MDS with deletion 5q chromosomal abnormality. In 2008, WHO introduced a new disease entity called MDS / MPN . No specific treatment for MDS / MPN subtype has yet been identified. We report a patient with MDS / MPN who responded well to lenalidomide therapy.

Cite

CITATION STYLE

APA

Islam, A. (2015). A case of myelodysplastic syndrome/myeloproliferative neoplasm ( MDS / MPN ) successfully treated with lenalidomide. Clinical Case Reports, 3(7), 551–552. https://doi.org/10.1002/ccr3.293

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free